首页> Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology> The optimal drug adherence to maximize the efficacy and safety of non-vitamin K antagonist oral anticoagulant in real-world atrial fibrillation patients.

The optimal drug adherence to maximize the efficacy and safety of non-vitamin K antagonist oral anticoagulant in real-world atrial fibrillation patients.

导出原文传递

翻译打印收藏纠错

第一作者： Daehoon,Kim

第一单位： Division of Cardiology, Department of Internal Medicine, Severance Cardiovascular Hospital, Yonsei University College of Medicine, MD. 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Republic of Korea.

作者： Daehoon,Kim ^[1] ; Pil-Sung,Yang ^[2] ; Eunsun,Jang ^[1] ; Hee Tae,Yu ^[1] ; Tae-Hoon,Kim ^[1] ; Jae-Sun,Uhm ^[1] ; Jong-Youn,Kim ^[1] ; Jung-Hoon,Sung ^[2] ; Hui-Nam,Pak ^[1] ; Moon-Hyoung,Lee ^[1] ; Gregory Y H,Lip ^[3] ; Boyoung,Joung ^[1]

作者单位： Division of Cardiology, Department of Internal Medicine, Severance Cardiovascular Hospital, Yonsei University College of Medicine, MD. 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Republic of Korea. ^[1] Department of Cardiology, CHA Bundang Medical Centre, CHA University, Seongnam, Republic of Korea. ^[2] Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital, Liverpool, UK.;Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark. ^[3]

关键词 Anticoagulation Atrial fibrillation Drug adherence Non-vitamin K antagonist oral anticoagulant Stroke Treatment outcome

医学主题词投药, 口服(Administration, Oral);抗凝药(Anticoagulants);心房颤动(Atrial Fibrillation);脑缺血(Brain Ischemia);人类(Humans);服药依从性(Medication Adherence);卒中(Stroke)

DOI 10.1093/europace/euz273

PMID 31598651

发布时间 2022-05-31

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交